Company / Revenue
CRESCENT BIOPHARMA, INC. Revenue History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$10.8M
FY2025
5-year range
$4.0M / $20.1M
FY2021-FY2025
Trend
-46.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $15M to $11M over the past 9 years.
Based on SEC 10-K filings.
$11M in FY2025 with a 10-year CAGR of +10.5%.
Declined from $15M to $11M over the past 9 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +10.5%
Key checks
Key Insights
- In FY2025, revenue decreased 46.0% year-over-year.
- Peak revenue was recorded in FY2017.
- Lowest revenue in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.8M | -46.0% |
| FY2017 | $20.1M | +33.6% |
| FY2016 | $15.0M | +276.4% |
| FY2015 | $4.0M | -73.8% |
| FY2014 | $15.3M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026